This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Pharma Mar, S.a.. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Alberto Rodríguez Vicente
Introduction
Alberto Rodríguez Vicente is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral compounds. With a total of 4 patents to his name, his work is paving the way for advancements in cancer treatment.
Latest Patents
Rodríguez Vicente's latest patents focus on antitumoral compounds. These compounds are characterized by a general formula (I) wherein various components, such as A, Y, W, and R, take on different meanings for use in the treatment of cancer. His innovative approach aims to enhance the efficacy of cancer therapies and improve patient outcomes.
Career Highlights
Alberto Rodríguez Vicente is currently associated with Pharma Mar, S.A., a leading biopharmaceutical company. His work at Pharma Mar has been instrumental in advancing research and development in oncology. His dedication to innovation in cancer treatment has established him as a key figure in the pharmaceutical industry.
Collaborations
Rodríguez Vicente collaborates with notable colleagues, including Carmen Murcia Pérez and Francisco Sánchez Sancho. These partnerships foster a collaborative environment that enhances the research and development process.
Conclusion
Alberto Rodríguez Vicente's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his innovative spirit and commitment to improving healthcare. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
